| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AA06 | B | Mycophenolic acid (sodium) - 360mg | 12446/388 | 13025/1 | MYFORTIC | 360mg | 120 | Tablet, gastroresistant | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Produktions GmbH, Wehr | Germany | L.L | 19.35 | D | Novartis Pharma AG | Switzerland | 1/13/202 |
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AA06 | B | Mycophenolic acid (sodium) - 360mg | 12446 | 13025/1 | MYFORTIC | 360mg | 120 | Tablet, gastroresistant | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Produktions GmbH, Wehr | Germany | 16,718,562 L.L | 19.35 | D | Novartis Pharma AG | Switzerland | 1/13/202 |

